Skip to content
SentinelMarket desk
Switch to dark mode

드림씨아이에스

223250KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

4,235KRWMarket close of 10/21 (Wed)

Up +12.78%+480KRWMarket close of 10/21 (Wed)

Open
3,775
High
4,610
Low
3,775
Day range
Day range low 3,775 high 4,610, open 3,775, close 4,235, previous close 3,755
Volume
232×10K shares
10.0B KRW 4.19× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 2,450 to 7,690 won, 34% up from the low

34% of the way up from the lowest close in 1 year (252 sessions) · -44.9% from the high

Something to check

2 to check: bigger daily move than usual · more trading value than usual

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveto check+12.78%+12.78%, 3.0× the usual (20-session average ±4.29%)
    That day +12.78% · usual ±4.29% · large-move threshold ±8.6%
  • Trading valueto check4.2×10.0B KRW, 4.2× the 20-session average
    4.19× the 20-session average · check threshold 3×
  • Recent filingsnot verifiedOutside filing data coverage, so not verified

The other 3

  • Foreign & institutionalnot verified
  • EarningsOperating income, 8 quartersOperating income, 8 quarters
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue17.4B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +22.9%
    vs. prior quarter
    -10.0%
  • Operating income538.74 million KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -59.4%
    vs. prior quarter
    Turned profitable
  • Operating margin3.1%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -6.3 pp
    vs. prior quarter
    +5.1 pp

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-05-14
2021Q1 601.07 million KRW2026Q1 538.74 million KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.